Analyzing the COVID-19 (coronavirus) situation is helping pharmaceutical companies to be better prepared in the upcoming months. Companies in the pharmaceutical water market are hard at work to keep up with regular orders whilst still supplying in demanding areas such as the Europe, the U.S., Russia, India, etc. Manufacturers are developing contingency plans to address future unprecedented situations. Flexibility is the key to maintain regular operations. Manufacturers in the pharmaceutical water market are increasing their research activities to flag alternatives pertaining to mission-critical suppliers and service providers.
Preparing for the unexpected is impossible; however, manufacturers should have a conceptual idea of steps to handle the situation of supply shortage. This will help businesses to withstand short-term crisis with minimized impact. Since the international trade is quite challenging in these unprecedented times, manufacturers are relying on local production.
The pharmaceutical water market is predicted to cross a revenue of US$ 71.9 Bn by 2030. This is evident since manufacturers are innovating in pharmaceutical-grade water purification systems. For instance, Puretech designs water purification systems for pharmaceutical, cosmetics, and biopharma industries. Service providers are offering installation, commission, and validation of purification systems to pharmaceutical end users. Innovations in these systems are becoming prominent in European countries where regional manufacturers are strengthening their global distribution chains.
Equipment manufacturers are complying with worldwide pharmacopoeia standards. Cutting-edge water purification systems are helping manufacturers in the pharmaceutical water market to gain recognition. Equipment companies are meeting client specifications and requirements to increase the uptake of systems. Pre-treatment activities are fueling the demand for pharmaceutical-grade water purification systems. Region-specific needs are being catered by equipment manufacturers due to different degrees of pre-treatment methods.
The pharmaceutical industry is heavily dependent on different degrees of water purity. However, limitations in reuse of water are likely to affect growth of manufacturers in the pharmaceutical water market. Hence, manufacturers are increasing their focus in scientific and technical literature sources to innovate in new methods of water reuse. This is important since the pharmaceutical industry is a highly water-dependent economic sector.
As per the European Union (EU), pharmaceutical, agriculture, and chemical industries make a great contribution to the GDP (Gross Domestic Product) of the EU economy. The high demand for stable water supply has compelled manufacturers in the pharmaceutical water market to adopt water reuse practices. Water reuse is ensuring sustainability of water resources and is improving water efficiency in the value chain.
The selection of best filtration methods is critical in pharmaceutical applications. As such, ultrafiltration is being used to filter large particles and viruses. However, certain dissolved substances within the medium are unable to be removed by ultrafiltration. Hence, manufacturers in the pharmaceutical water market are increasing their R&D efforts to adopt alternative filtration processes such as nanofiltration and reverse osmosis. Thus, improved production practices are contributing toward the favorable growth of the market, which is estimated to progress at a CAGR of ~10% from 2020 to 2030.
Reverse osmosis is synonymous with the process of refining antibiotics and concentration of hormones within the pharmaceutical industry. Companies in the pharmaceutical water market are using filtration processes for plasma fractionation and red biotechnology.
Analysts’ Viewpoint
Nanofiltration and reverse osmosis methods are being highly publicized for killing viruses during filtration amidst the ongoing COVID-19 crisis. Pharmaceutical-grade water purification systems help to generate purified water, which is utilized in specialty enzymes, diagnostics, and white biotechnology applications. Technological innovations in these systems involve automatic thermal sanitization and continuous electrodeionisation. However, companies in the Europe pharmaceutical water market need to abide by stringent regulations of the EU. Hence, companies should adopt reuse practices for maintaining water efficiency and establishing sustainability of water resources in the value chain. This will help to maximize opportunities for safe reuse of different grades of water.
Pharmaceutical Water Market – Segmentation
|
Type |
|
|
End User |
|
|
Region |
|
The global pharmaceutical water market was worth US$ 24.3 Bn and is projected to reach a value of US$ 71.9 Bn by the end of 2030
Pharmaceutical water market is anticipated to grow at a CAGR of 10% during the forecast period
North America accounted for a major share of the global pharmaceutical water market
Pharmaceutical Water Market is driven by rapid increase in burden of diabetes among the geriatric and obese population across the globe is a major factor likely to propel the global market
Key players in the global pharmaceutical water market include Merck KGaA, B. Braun Melsungen AG, Baxter International, Inc., Thermo Fisher Scientific, Inc., Cytiva (Danaher), Intermountain Life Sciences, Standard Reagents, Pvt. Ltd., CovaChem, LLC., FUJIFILM Irvine Scientific, Fresenius Kabi AG, and Pfizer, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pharmaceutical Water Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pharmaceutical Water Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Pricing Analysis
5.2. Technological Advancements
5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Pharmaceutical Water Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Pharmaceutical Water Market Value Forecast, by Type, 2018–2030
6.3.1. HPLC Grade Water
6.3.2. Water for Injection
6.4. Global Pharmaceutical Water Market Attractiveness Analysis, by Type
7. Global Pharmaceutical Water Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030
7.3.1. Pharmaceutical & Biotechnology Companies
7.3.2. Academics & Research Laboratories
7.3.3. Others (medical device manufacturing)
7.4. Global Pharmaceutical Water Market Attractiveness Analysis, by End-user
8. Global Pharmaceutical Water Market Analysis and Forecast, by Region
8.1. 10.1. Key Findings
8.2. 10.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Pharmaceutical Water Market Attractiveness Analysis, by Region
9. North America Pharmaceutical Water Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Pharmaceutical Water Market Value Forecast, by Type, 2018–2030
9.2.1. HPLC Grade Water
9.2.2. Water for Injection
9.3. North America Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. Academics & Research Laboratories
9.3.3. Others (medical device manufacturing)
9.4. North America Pharmaceutical Water Market Value Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America Pharmaceutical Water Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By Application
9.5.3. By End-user
9.5.4. By Country
10. Europe Pharmaceutical Water Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Pharmaceutical Water Market Value Forecast, by Type, 2018–2030
10.2.1. HPLC Grade Water
10.2.2. Water for Injection
10.3. Europe Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030
10.3.1. Pharmaceutical & Biotechnology Companies
10.3.2. Academics & Research Laboratories
10.3.3. Others (medical device manufacturing)
10.4. Europe Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Pharmaceutical Water Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By Application
10.5.3. By End-user
10.5.4. By Country/Sub-region
11. Asia Pacific Pharmaceutical Water Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Pharmaceutical Water Market Value Forecast, by Type, 2018–2030
11.2.1. HPLC Grade Water
11.2.2. Water for Injection
11.3. Asia Pacific Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030
11.3.1. Pharmaceutical & Biotechnology Companies
11.3.2. Academics & Research Laboratories
11.3.3. Others (medical device manufacturing)
11.4. Asia Pacific Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Pharmaceutical Water Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By Application
11.5.3. By End-user
11.5.4. By Country/Sub-region
12. Latin America Pharmaceutical Water Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Pharmaceutical Water Market Value Forecast, by Type, 2018–2030
12.2.1. HPLC Grade Water
12.2.2. Water for Injection
12.3. Latin America Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030
12.3.1. Pharmaceutical & Biotechnology Companies
12.3.2. Academics & Research Laboratories
12.3.3. Others (medical device manufacturing)
12.4. Latin America Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Pharmaceutical Water Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By Application
12.5.3. By End-user
12.5.4. By Country/Sub-region
13. Middle East & Africa Pharmaceutical Water Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Pharmaceutical Water Market Value Forecast, by Type, 2018–2030
13.2.1. HPLC Grade Water
13.2.2. Water for Injection
13.3. Middle East & Africa Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030
13.3.1. Pharmaceutical & Biotechnology Companies
13.3.2. Academics & Research Laboratories
13.3.3. Others (medical device manufacturing)
13.4. Middle East & Africa Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By Application
13.5.3. By End-user
13.5.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2019
14.3. Company Profiles
14.3.1. Merck KGaA
14.3.1.1. Company Overview
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. B. Braun Melsungen AG
14.3.2.1. Company Financials
14.3.2.2. Growth Strategies
14.3.2.3. SWOT Analysis
14.3.3. Baxter International, Inc.
14.3.3.1. Company Overview
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Thermo Fisher Scientific, Inc.
14.3.4.1. Company Overview
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Cytiva (Danaher)
14.3.5.1. Company Overview
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Intermountain Life Sciences
14.3.6.1. Company Overview
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Standard Reagents, Pvt. Ltd.
14.3.7.1. Company Overview
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. CovaChem, LLC.
14.3.8.1. Company Overview
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. FUJIFILM Irvine Scientific
14.3.9.1. Company Overview
14.3.9.2. Company Financials
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. Fresenius Kabi AG
14.3.10.1. Company Overview
14.3.10.2. Company Financials
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
14.3.11. Pfizer, Inc.
14.3.11.1. Company Overview
14.3.11.2. Company Financials
14.3.11.3. Growth Strategies
14.3.11.4. SWOT Analysis
14.3.12. Other Prominent Key Players
List of Tables
Table 01: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 02: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 03: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 04: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 05: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 06: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 07: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 08: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 09: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 10: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 11: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 12: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 15: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 16: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 18: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Pharmaceutical Water Market Value Share, by Region, 2019
Figure 03: Global Pharmaceutical Water Market Value Share, by Type, 2019
Figure 04: Global Pharmaceutical Water Market Value Share, by End-user, 2019
Figure 05: Global Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030
Figure 06: Global Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030
Figure 07: Global Pharmaceutical Water Market Revenue (US$ Mn), by HPLC Grade Water, 2018–2030
Figure 08: Global Pharmaceutical Water Market Revenue (US$ Mn), by Water for Injection, 2018–2030
Figure 09: Global Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030
Figure 10: Global Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030
Figure 11: Global Pharmaceutical Water Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2018–2030
Figure 12: Global Pharmaceutical Water Market Revenue (US$ Mn), by Academics & Research Laboratories, 2018–2030
Figure 13: Global Pharmaceutical Water Market Revenue (US$ Mn), by Others, 2018–2030
Figure 14: Global Pharmaceutical Water Market Value Share Analysis, by Region, 2019 and 2030
Figure 15: Global Pharmaceutical Water Market Attractiveness Analysis, by Region, 2020–2030
Figure 16: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030
Figure 17: North America Pharmaceutical Water Market Value Share Analysis, by Country, 2019 and 2030
Figure 18: North America Pharmaceutical Water Market Attractiveness Analysis, by Country, 2020–2030
Figure 19: North America Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030
Figure 20: North America Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030
Figure 21: North America Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030
Figure 22: North America Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030
Figure 23: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030
Figure 24: Europe Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 25: Europe Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 26: Europe Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030
Figure 27: Europe Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030
Figure 28: Europe Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030
Figure 29: Europe Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030
Figure 30: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030
Figure 31: Asia Pacific Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 32: Asia Pacific Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 33: Asia Pacific Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030
Figure 34: Asia Pacific Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030
Figure 35: Asia Pacific Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030
Figure 36: Asia Pacific Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030
Figure 37: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030
Figure 38: Latin America Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 39: Latin America Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 40: Latin America Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030
Figure 41: Latin America Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030
Figure 42: Latin America Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030
Figure 43: Latin America Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030
Figure 44: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030
Figure 45: Middle East & Africa Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 46: Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 47: Middle East & Africa Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030
Figure 48: Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030
Figure 49: Middle East & Africa Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030
Figure 50: Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pharmaceutical Water Market
